Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,037 public trials 1,027 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Completed

Ask Questions (ASQ):Implementation of a Communication Intervention

NCT05025748

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +68 more
Locations
  • Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States
  • Karmanos Cancer Institute at McLaren Clarkston Clarkston, Michigan, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States
View Trial Details
Completed

A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.

NCT04495179

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Research Site Sacramento, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site St Louis, Missouri, United States
View all 16 locations
View Trial Details
Completed

SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer

NCT01075308

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
View Trial Details
Completed

Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

NCT00258388

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of Washington Seattle, Washington, United States
  • Tom Baker Cancer Centre Calgary, Canada
  • Cross Cancer Institute Edmonton, Canada
  • QEII Health Sciences Center Halifax, Canada
View all 13 locations
View Trial Details
Completed

Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer

NCT01619813

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Abbotsford Centre Abbotsford British Columbia, British Columbia, Canada
  • BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada
View Trial Details
Completed

Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer

NCT00093457

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada
  • British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
  • British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View Trial Details

Related conditions